Inhibition of mouse macrophages interleukin-12 production: suppression of nuclear factor-kappaB binding activity by a specific factor isolated from Scapharca broughtonii.
Pharmacological inhibition of interleukin-12 (IL-12) production may allow a therapeutic strategy for preventing development and progression of disease in experimental models of autoimmunity. In this study we investigated the effects of an ethanol fraction of the Scapharca broughtonii, on the production of IL-12 by mouse macrophages stimulated with lipopolysaccharides (LPS). The ethanol fraction (S3) prepared from Scapharca broughtonii potently inhibited LPS-induced IL-12 production in the RAW264.7 monocyte cell-line in a dose-dependent manner. The activation effect of the ethanol fraction (S3) on the IL-12 gene promoter was analyzed by transfecting RAW264.7 cells with IL-12 gene promoter/luciferase constructs. The repressive effect mapped to a region in the IL-12 gene promoter that contained a binding site for NF-kappaB. Furthermore, activation of macrophages by LPS resulted in markedly enhanced binding activity to the NF-kappaB site, which significantly decreased upon addition of the ethanol fraction, indicating that the ethanol fraction of the blood shell inhibited IL-12 production in LPS-activated macrophages via inhibition of NF-kappaB binding activity.
Kim
Seung Hyun
SH
School of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Korea.
Kim
Tae Sung
TS
Lee
June Woo
JW
Ha
Jung Wan
JW
Park
Nae Soo
NS
Lee
Hyo Jung
HJ
Yoo
Jin Cheol
JC
D000818:Animals; D002478:Cells, Cultured; D018664:Interleukin-12 / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D008264:Macrophages / Q000187:drug effects* / Q000276:immunology; D051379:Mice; D016328:NF-kappa B / Q000037:antagonists & inhibitors* / Q000378:metabolism; D049894:Scapharca / Q000737:chemistry*
D016328:NF-kappa B; D018664:Interleukin-12